Bevacizumab Nwgd + Irinotecan Interaction
Minorinteraction on record
Description
No clinically meaningful effect on the pharmacokinetics of irinotecan or its active metabolite SN38 when bevacizumab was administered in combination.
Source: NLP:bevacizumab-nwgd